AR
ITCI
Advisory Research’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-25,333
| Closed | -$1.32M | – | 487 |
|
|
2023
Q3 | $1.32M | Buy |
25,333
+3,412
| +16% | +$178K | 0.18% | 155 |
|
|
2023
Q2 | $1.39M | Buy |
21,921
+17,515
| +398% | +$1.11M | 0.18% | 159 |
|
|
2023
Q1 | $239K | Buy |
+4,406
| New | +$239K | 0.04% | 313 |
|
|
2022
Q3 | – | Sell |
-36,414
| Closed | -$2.08M | – | 410 |
|
|
2022
Q2 | $2.08M | Sell |
36,414
-4,141
| -10% | -$236K | 0.2% | 83 |
|
|
2022
Q1 | $2.48M | Buy |
40,555
+7,451
| +23% | +$456K | 0.2% | 80 |
|
|
2021
Q4 | $1.73M | Buy |
33,104
+25,165
| +317% | +$1.32M | 0.14% | 134 |
|
|
2021
Q3 | $296K | Buy |
+7,939
| New | +$296K | 0.02% | 299 |
|